3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
6
Hematologic Neoplasms
5
Breast Neoplasms
4
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Glioma
3
Colorectal Neoplasms
3
Prostatic Neoplasms
2
Neoplasms by Site
2
Motor Activity
2
Head and Neck Neoplasms
2
Glioblastoma
2
Carcinoma, Transitional Cell
2
Anxiety Disorders
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uveal Melanoma
1
Uterine Neoplasms
1
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urinary Bladder Diseases
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Smoking Cessation
1
Small Cell Lung Carcinoma
1
Interventions
Standard of Care
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Mycoses
×
Standard of Care
×
Clear all
NCT03301597
2021-03-30
LAUNCH
Nohla Therapeutics, Inc.
Phase 2
Terminated
146 enrolled